Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-867-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
- Acute oral toxicity, OECD 420, rats, LD50 > 2000 mg/kg bw
- Acute dermal toxicity, OECD 402, rats, LD50 > 2000 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2006-12-20 to 2007-01-18
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Statement of GLP Compliance No. G 024 (Slovak National Accreditation Service); Statement of GLP Compliance No. 4/2006/DPL.
- Test type:
- fixed dose procedure
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: conventional farm of laboratory animals run by the Institute of Occupational Medicine in Łódź, Poland.
- Age at study initiation: Pilot study: 9 week; Main experiment: 11 weeks
- Weight at study initiation: Pilot study: 166 g; Main experiment: average body weight of 190.5 g.
- Fasting period before study: yes. The day before the experiment was due to commence, some 18 hours before administration of the analysed material, the animals were deprived of feed, being left with only water. Feed was made available again 3 hours after administration of the analysed substance.
- Housing: plastic cages with metal wire covers, with the following dimensions (length x width x height): 58 x 37 x 21 cm.
During the experiment, the animals were kept in cages individually (initial study) and in groups of four (study proper). The litter comprised dedusted wood shavings, sterilised with ultraviolet radiation. Each cage was fitted with a signboard containing the study code, the dose applied, the date of commencement and planned termination of the experiment, as well as the sex and individual numbers of animals.
- Diet (e.g. ad libitum): ad libitum (standard granulated "Murigran" laboratory feed, manufactured by Wytwórnia Koncentratów i Mieszanek Paszowych AGROPOL of Motycz)
- Water (e.g. ad libitum): ad libitum (tap water)
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-21
- Humidity (%): 45-71
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES:
The analysed substance was administered to the rats on the following days: 20.12.2006. (1 female – initial experiment, dose of 2,000 mg/kg of body mass) and 04.01.2007. (4 females – experiment proper, dose of 2,000 mg/kg of body mass). The experiment was terminated on the following days: 03.01.2007 (1 female – initial experiment, dose of 2,000 mg/kg of body mass) and 18.01.2007 (4 females – experiment proper, dose of 2,000 mg/kg of body mass), respectively. - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 1 mL of the water solution of the analysed substance contained: 400 mg of the substance (dose of 2,000 mg/kg b.w.);
- Amount of vehicle (if gavage): 0.5 mL per 100 g of the body weight. - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- Initial experiment: one animal
Main strudy: four animals - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: An assessment of the general condition of the animals, i.e. observation of all animals in terms of incidence and mortality, was performed twice daily throughout the 14-day duration of the experiment. Detailed clinical observations were performed on the day of administration of the analysed substance (day 0), 10, 30 and 60 minutes after administration, and subsequently every hour over a period of 5 hours from the time of administration. On successive days of the 14-day period of the experiment – once daily.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight. - Preliminary study:
- Following the single administration of the analysed substance, this in a dose of 2,000 mg/kg of body mass, to one female (initial experiment), no symptoms of toxicity were observed during the 14-day period of observation. The female survived the 14-day period of observation.
Following the single administration of the analysed substance, this in a dose of 2,000 mg/kg of body mass, to four successive females (experiment proper), no symptoms of toxicity were observed during the 14-day period of observation for three of the animals. The females survived the 14-day observation period. - Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- >= 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: based on mortality, clinical signs and findings at necropsy at 2000 mg/kg bw
- Mortality:
- All females survived the 14-day observation period.
- Clinical signs:
- other: Following the single administration of the analysed substance, this in a dose of 2,000 mg/kg of body mass, to one female (initial experiment), no symptoms of toxicity were observed during the 14-day period of observation. Following the single administrati
- Gross pathology:
- No pathological changes were found during the macroscopic study in the analysed animals.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- On the grounds of the study, it may be stated that the median lethal dose (LD50) of Mn (II) IDHA is greater than 2000 mg/kg b.w.
- Executive summary:
A study was conducted to test oral toxicity potential of Mn (II) IDHA in rats. Following the single administration of the analysed substance in a dose of 2,000 mg/kg b.w. to a single female, no symptoms of toxicity were observed during the 14-day period of observation. The female survived the 14-day period of observation. Following the single administration of the analysed substance in a dose of 2,000 mg/kg bw to four successive females, no symptoms of toxicity were observed during the 14-day period of observation. The females survived the 14-day observation period. All the animals were put down following the 14-day period of observation and subsequently underwent autopsies and macroscopic studies. No pathological changes were found during the macroscopic study in the studied animals.
Reference
Table 1. Mn (II) IDHA Acute oral toxicity study conducted on rats – clinical symptoms – summary breakdown
Dose(mg/kg b.w.) |
Day following administration |
Number of live animals |
Rat no. |
||||
1* |
2 |
3 |
4 |
5 |
|||
2,000 |
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 |
BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ |
BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ |
BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ |
BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ |
BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ BZ |
* female from the initial experiment
BZ = without change
Table 2. Mn (II) IDHA Acute oral toxicity study conducted on rats - animal body mass (g)
Dose mg/kg b.w. |
Rat no. |
Day of experiment |
Difference 14 – 0 |
||
0 |
7 |
14 |
|||
2,000 |
1* 2 3 4 5 |
166 183 198 188 193 |
215 210 227 206 228 |
236 219 229 216 232 |
70 36 31 28 39 |
* females from the initial experiment
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The study is conducted in accordance with OECD 420, is GLP compliant and has Klimish score 1.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from 2013-10-01 to 2013-10-16
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: well documented GLP Guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: SOP/T/21: „Acute dermal toxicity study”
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bureau of Chemical Substances
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: husbandry of laboratory animals of the Experimental Medicine Centre at the Medical University in Białystok kept behind the breeding barrier (number in the register of units entitled to the husbandry of laboratory animals: 0043).
- Age at study initiation: 8 weeks old
- Weight at study initiation: 282.8 g (males) and 211.4 g (females)
- Fasting period before study: none
- Housing: in plastic cages covered with wi re bar lids. The dimensions of the cages were 58 x 37 x 21 cm (length x width x height). After the application of the test item, each animal was housed individually. After the removal of the test item from the animals’ skin, there were five rats per cage. Each sex was kept separately. UV-sterilized wood shavings were used as bedding. Each cage was equipped with a label containing the study code, the dose, the dates of the commencement and the expected termination of the experiment, and the animals’ sex and numbers
- Diet (e.g. ad libitum): ad libitum to “Murigran” standard granulated fodder produced by Wytwórnia Koncentratów i Mieszanek Paszowych AGROPOL, Motycz
- Water (e.g. ad libitum): ad libitum, tap water
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 - 23 °C;
- Humidity (%): 35 – 58 %
- Air changes (per hr): about 16 times/hour
- Photoperiod (hrs dark / hrs light): 12 / 12 - Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: ca. 41 cm² (males) ca. 31 cm² (females)
- Type of wrap if used: gauze patches were covered with PCV foil and elastic bandage was used to make circular protecting band
REMOVAL OF TEST SUBSTANCE
- Washing (if done): water
- Time after start of exposure: 24 hours after application of chemical and immediately after removal of the gauze patch
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2000 mg/kg bw
- Constant volume or concentration used:no
- For solids, paste formed: no (The test item was ground, applied to gauze patches, and moistened with a few drops of water. Then, the patches were laid on the prepared skin.)
VEHICLE
- Amount(s) applied (volume or weight with unit): a few drops of water were applied to the ground test item, which was applied to gauze patches - Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: General and detailed clinical observations of all animals were performed daily during the entire experiment. Body weights of the animals were determined on days 0 (di rectly before the application of the test item), 7, and 14. After the 14-day observation period, the animals were euthanized, dissected, and subjected to detailed gross examinations.
- Other examinations performed: clinical signs, body weight, gross necropsy - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All animals survived the experiment.
- Clinical signs:
- other: no general signs of toxicity were stated in the animals. No pathological skin changes in the site of the test item application were noticed in all males and three females (no. 2, 4, and 5). Skin dryness was stated in two females (no.1 and 3).Moreover, sca
- Gross pathology:
- Gross examinations did not reveal any pathological changes in the examined animals.
- Other findings:
- no other findings reported
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- On the grounds of the study, it may be stated that the median lethal dose (LD50) of Mn (II) IDHA is greater than 2000 mg/kg b.w.
- Executive summary:
A study was conducted to test the dermal toxicity potential of Mn (II) IDHA in rats (Kropidlo, A., 2013). Following single application of the test item, the animals did not exhibit any general clinical signs. No pathological skin changes on the site of the test item application were noticed in all males and three females (no. 2, 4, and 5). Skin dryness was stated in two females (no. 1 and 3). Moreover, scabs were stated in one female (no. 3). All animals survived the experiment. During the 14-day experiment, body weight gain was stated in all animals. Gross examinations did not reveal any pathological changes in the examined animals. On the grounds of the study, it may be stated that the median lethal dose (LD50) of Mn (II) IDHA is greater than 2000 mg/kg b.w.
Reference
Following single application of the test item, the animals did not exhibit any general clinical signs. No pathological skin changes in the site of the test item application were noticed in all males and three females (no. 2, 4, and 5). Skin dryness was stated in two females (no. 1 and 3). Moreover, scabs were stated in one female (no. 3). All animals survived the experiment. During the 14-day experiment, body weight gain was stated in all animals. Gross examinations did not reveal any pathological changes in the examined animals.
Table 1: Summary of results
Mn (II) IDHA: acute dermal toxicity study on rats | ||
Dose of test item(mg/kg b.w.) | 2000 | |
Sex | males | females |
Mortality | 0/5 | 0/5 |
Clinical signs | no changes | no changes were stated (no 2, 4, and 5) |
skin dryness was stated (no 1 and 3) | ||
scabs were stated (no. 3) | ||
Clinical signs
Following single application of the test item, the animals did not exhibit any general clinical signs. No pathological skin changes in the site of the test item application were noticed in all males and three females (no. 2, 4, and 5). Skin dryness was stated in two females (no. 1 and 3) between the 2nd and the 3rd day after the application. Moreover, scabs were stated in one female (no. 3) between the 2nd and the 3rd day after the application. All animals survived the experiment. An overall list of the results of the clinical observations is presented in Table 2.
Table 2 - Clinical signs - overall list | ||||||||
Mn (II) IDHA: acute dermal toxicity study on rats | ||||||||
Dose (mg/kg b.w.) | Sex | Day after application | Number of living animals | Rat number | ||||
1 | 2 | 3 | 4 | 5 | ||||
2000 | males | 0 | 5 | NC | NC | NC | NC | NC |
1 | 5 | NC | NC | NC | NC | NC | ||
2 | 5 | NC | NC | NC | NC | NC | ||
3 | 5 | NC | NC | NC | NC | NC | ||
4 | 5 | NC | NC | NC | NC | NC | ||
5 | 5 | NC | NC | NC | NC | NC | ||
6 | 5 | NC | NC | NC | NC | NC | ||
7 | 5 | NC | NC | NC | NC | NC | ||
8 | 5 | NC | NC | NC | NC | NC | ||
9 | 5 | NC | NC | NC | NC | NC | ||
10 | 5 | NC | NC | NC | NC | NC | ||
11 | 5 | NC | NC | NC | NC | NC | ||
12 | 5 | NC | NC | NC | NC | NC | ||
13 | 5 | NC | NC | NC | NC | NC | ||
14 | 5 | NC | NC | NC | NC | NC | ||
females | 0 | 5 | NC | NC | NC | NC | NC | |
1 | 5 | NC | NC | NC | NC | NC | ||
2 | 5 | SIGNS | NC | SIGNS | NC | NC | ||
3 | 5 | SIGNS | NC | SIGNS | NC | NC | ||
4 | 5 | NC | NC | NC | NC | NC | ||
5 | 5 | NC | NC | NC | NC | NC | ||
6 | 5 | NC | NC | NC | NC | NC | ||
7 | 5 | NC | NC | NC | NC | NC | ||
8 | 5 | NC | NC | NC | NC | NC | ||
9 | 5 | NC | NC | NC | NC | NC | ||
10 | 5 | NC | NC | NC | NC | NC | ||
11 | 5 | NC | NC | NC | NC | NC | ||
12 | 5 | NC | NC | NC | NC | NC | ||
13 | 5 | NC | NC | NC | NC | NC | ||
14 | 5 | NC | NC | NC | NC | NC | ||
NC - no changes | ||||||||
SIGNS - clinical signs |
Body weights of the animals
During the 14-day experiment, body weight gain was stated in all animals. The individual results of body weight measurements are presented in Table 3
Table 3- Bodyweight of animals (g)-overall list | ||||||
Mn(II)IDHA:acute dermal toxicity study on rats | ||||||
Dose(mg/kgb.w.) | Sex | Rat No | Day of experiment/Body weight(g) | Body weight gain(g)(0-14) | ||
0 | 7 | 14 | ||||
2000 | males | 1 | 298 | 330 | 362 | 64 |
2 | 285 | 305 | 326 | 41 | ||
3 | 300 | 325 | 361 | 61 | ||
4 | 243 | 262 | 280 | 37 | ||
5 | 288 | 301 | 322 | 34 | ||
females | 1 | 203 | 220 | 230 | 27 | |
2 | 215 | 229 | 245 | 30 | ||
3 | 208 | 223 | 231 | 23 | ||
4 | 211 | 223 | 233 | 22 | ||
5 | 220 | 237 | 252 | 32 |
Gross examinations
The gross examinations did not reveal any pathological changes in the examined animals.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The study is conducted in accordance with OECD 402, is GLP compliant and has Klimish score 1.
Additional information
Acute toxicity: oral
A study was conducted to test oral toxicity potential of Mn(2Na)IDHA in rats (Gruszka, 2007, Report No. OS-45/06, according to OECD 420). Following the single administration of the analysed substance in a dose of 2000 mg/kg bw to a single female, no symptoms of toxicity were observed during the 14-day period of observation. The female survived the 14-day period of observation. Following the single administration of the analysed substance in a dose of 2000 mg/kg bw to four successive females, no symptoms of toxicity were observed during the 14-day period of observation The females survived the 14-day observation period. All the animals were put down following the 14-day period of observation and subsequently underwent autopsies and macroscopic studies. No pathological changes were found during the macroscopic study in the studied animals. LD50 of greater than 2000 mg/kg bw was established.
Acute toxicity: dermal
A study was conducted to test the dermal toxicity potential of Mn(2Na)IDHA in rats (Kropidlo, 2013, Report No. DER-11/13, according to OECD 402). Following single application of the test item, the animals did not exhibit any general clinical signs. No pathological skin changes in the site of the test item application were noticed in all males and three females (no. 2, 4, and 5). Skin dryness was stated in two females (no. 1 and 3). Moreover, scabs were stated in one female (no. 3). All animals survived the experiment. During the 14-day experiment, body weight gain was stated in all animals. Gross examinations did not reveal any pathological changes in the examined animals. On the grounds of the study, it may be stated that the median lethal dose (LD50) of Mn(2Na)IDHA is greater than 2000 mg/kg bw.
Justification for selection of acute toxicity – oral endpoint
Only one study available
Justification for selection of acute toxicity – dermal endpoint
Only one study is available
Justification for classification or non-classification
Based on LD50 of greater than 2000 mg/kg bw established in the oral acute toxicity study, Mn(2Na)IDHA is not subject to classification and labelling for acute toxic effects by oral route of exposure according to European Regulation (EC) No. 1272/2008.
Based on LD50 of greater than 2000 mg/kg bw established in the dermal acute toxicity study, Mn(I2Na)IDHA is not subject to classification and labelling for acute toxic effects by dermal route of exposure according to European Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.